Ceribell, Inc.
CBLLNasdaqHealthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | |
|---|---|---|---|
| Revenue | $89.1M | $65.4M | $45.2M |
| Operating income | −$58.4M | −$39.7M | −$30.0M |
| Net income | −$53.4M | −$40.5M | −$29.5M |
| Total assets | $195.8M | $225.4M | $58.9M |
| Total liabilities | $40.5M | $34.2M | $23.8M |
| Equity | $155.3M | $191.2M | −$112.3M |
| EPS (diluted) | $-1.46 | $-3.39 | $-5.56 |
| Shares out. | 35.9M | 35.9M | 5.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −65.6%
- Net margin
- −60.0%
- Return on equity
- −34.4%
- Return on assets
- −27.3%
- Return on capital (ROCE)
- −33.1%
- Liabilities / assets
- 20.7%
- Debt / equity
- 0.26×
- Book value / share
- $4.33
- Revenue growth (YoY)
- 36.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 3.97safe
- Accruals / assets
- −6.4%clean
- Beneish M-Score
- -2.42normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 warning● 4 good- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Global Value Investment Portfolio Management Pte LtdPassive (13G)May 14, 2026
- Chao XingjuanPassive (13G)May 12, 2026
- Fmr LlcPassive (13G)May 6, 2026
- Abg Management Ltd.Passive (13G)Dec 11, 2025
- Red Tree Gp, LlcPassive (13G)Feb 14, 2025
- Tpg Gp A, LlcPassive (13G)Feb 13, 2025
- Parvizi JosefPassive (13G)Feb 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Manni Joseph S.Officer — Chief Revenue Officer | May 21, 2026 | Sell | 1,378 | $18.00 |
| Foehr DavidOfficer — Senior VP, Finance and PAO | May 21, 2026 | Sell | 987 | $18.00 |
| Woo RaymondOfficer — Chief Technology Officer | May 21, 2026 | Sell | 1,966 | $18.00 |
| Blumberg ScottOfficer — Chief Financial Officer | May 21, 2026 | Sell | 1,387 | $18.00 |
| Chao XingjuanOfficer — President and CEO | May 21, 2026 | Sell | 6,030 | $18.00 |
| Chao XingjuanOfficer — President and CEO | May 5, 2026 | Sell | 14,000 | $20.12 |
| Woo RaymondOfficer — Chief Technology Officer | May 1, 2026 | Option exercise | 1,469 | $2.24 |
| Chao XingjuanOfficer — President and CEO | Apr 6, 2026 | Sell | 14,000 | $18.40 |
| Chao XingjuanOfficer — President and CEO | Apr 1, 2026 | Grant | 97,555 | $0.00 |
| Blumberg ScottOfficer — Chief Financial Officer | Apr 1, 2026 | Grant | 30,736 | $0.00 |
| Foehr DavidOfficer — Senior VP, Finance and PAO | Apr 1, 2026 | Grant | 22,050 | $0.00 |
| Manni Joseph S.Officer — Chief Revenue Officer | Apr 1, 2026 | Grant | 30,736 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.0M | 4.9 | +4.1% |
| Apr 30, 2026 | 1.9M | 8.1 | +23.1% |
| Apr 15, 2026 | 1.5M | 6.1 | -18.6% |
| Mar 31, 2026 | 1.9M | 6.6 | +13.3% |
| Mar 13, 2026 | 1.7M | 5.2 | -13.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 11, 2026
- Results of operationsFeb 24, 2026
- Other material eventJan 5, 2026
- Director / officer changeJan 2, 2026
- Entered a material agreementDec 12, 2025
- Other material eventDec 9, 2025
- Other material eventNov 24, 2025
- Results of operationsNov 4, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.